Veliparib alone or in combination with mitomycin C in patients with solid tumors with functional deficiency in homologous recombination repair

Medicine & Life Sciences

• veliparib 100%
• Fanconi Anemia 77%
• Mitomycin 63%
• Fluorescent Antibody Technique 24%
• Coloring Agents 23%
• Neoplasms 18%
• Poly(ADP-ribose) Polymerase Inhibitors 15%
• Arm 10%
• Nonsense Codon 6%
• Germ-Line Mutation 6%
• Missense Mutation 5%
• Thrombocytopenia 5%
• Non-Small Cell Lung Carcinoma 5%
• Fatigue 4%
• Diarrhea 4%
• Genes 4%
• Breast 4%
• Safety 3%
• Mutation 3%